IL10 and myeloid sarcoma: Furthermore, the bone-protective effect of IL-10 and the increase in IL-10 in the remission phase in MS could explain why relatively low PD with otherwise elevated clinical parameters of the MPI and BOP index (which can be seen in patients with signs of gingivitis) were present in our study [32].